For example, mutations or deletions in the human E3-ubiquitin ligase-coding gene PARK2 that lead to increased levels of cyclin E and re-entry of the cell cycle, are associated with both, several malignancies and early onset Parkinson’s disease (Morris et al. 2010). This evidence concerns the gene CCNE1 and Parkinson disease.